Hydromorphone combined with ropivacaine for erector spinae plane block in patients undergoing modified radical mastectomy: A prospective randomized controlled trial

Author:

Cao Xue12ORCID,Bao Malian3,Ma Yuhua2,Ren Jie2,Ma Weiwei2,Bao Yongli2,Ma Changfei2,Sui Xin2,Nie Yongzhen4

Affiliation:

1. Graduate School of Inner Mongolia Medical University, Hohhot, China

2. Department of Anesthesiology, Xing’anmeng People’s Hospital, Ulanhot, China

3. Department of Anesthesiology, Inner Mongolia Forth Hospital, Hohhot, China

4. Department of Anesthesiology, Peking University Cancer Hospital Inner Mongolia Hospital, Hohhot, China.

Abstract

Background: Combining hydromorphone with ropivacaine in ultrasound-guided erector spinae plane blocks enhances postoperative analgesia and reduces interleukin-6 expression in breast surgery patients. Methods: In this study, breast cancer patients undergoing modified radical mastectomy were randomized into 3 groups for anesthesia (30 patients in each group): standard general (group C), Erector Spinae Plane Block (ESPB) with ropivacaine (group R), and ESPB with ropivacaine plus hydromorphone (group HR). Diagnosis: Breast cancer patients. Postsurgery, pain levels, IL-6, anesthetic doses, additional analgesia needs, and recovery milestones were compared to evaluate the efficacy of the ESPB enhancements. Results: The 3 groups were not significantly different in baseline characteristics, operation time, number of cases with postoperative nausea, and serum IL-6 concentrations at T1 (the time of being returned to the ward after surgery). At T2 (at 6:00 in the next morning after surgery), the serum IL-6 concentration in group HR was significantly lower than that in groups R and C (P < .05); the intraoperative doses of remifentanil, sufentanil, and propofol were significantly lower in groups HR and R than those in group C (P < .05); Groups HR and R had significantly lower visual analog scale scores at T3 (4 hours postoperatively), T4 (12 hours postoperatively), and T5 (24 hours postoperatively) than those in group C (P < .05); the proportions of patients receiving postoperative remedial analgesia were significantly lower in groups HR and R than in group C (P < .05); groups HR and R had significantly lower proportions of patients with postoperative nausea than group C (P < .05); the time to the first anal exhaust and the time to the first ambulation after surgery were significantly shorter in groups HR and R than those in group C (P < .05). Conclusion: Hydromorphone combined with ropivacaine for ESPB achieved a greater postoperative analgesic effect for patients receiving MRM under general anesthesia. The combined analgesia caused fewer adverse reactions and inhibited the expression level of the inflammatory factor IL-6 more effectively, thereby facilitating postoperative recovery. ESPB using hydromorphone with ropivacaine improved pain control post-MRM, reduced adverse effects, and more effectively suppressed IL-6, enhancing recovery.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference17 articles.

1. Prophylaxis of postoperative nausea and vomiting in patients scheduled for breast surgery.;Fujii;Clin Drug Investig,2006

2. Effect of proinflammatory factors TNF-α,IL-1β, IL-6 on neuropathic pain.;Li;Zhongguo Zhong Yao Za Zhi,2017

3. A large randomized trial: effects of Mindfulness-Based Stress Reduction (MBSR) for breast cancer (BC) survivors on salivary cortisol and IL-6.;Lengacher;Biol Res Nurs,2019

4. A survey on psychological problems in breast cancer patients after surgery and nursing measures.;Huang;Guide China Med,2022

5. Perioperative breast analgesia: a qualitative review of anatomy and regional techniques.;Woodworth;Reg Anesth Pain Med,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3